
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
EP58 CRISPR/Cas9 KO Plasmid (h) | sc-407615 | 20 µg | $397.00 | |||
EP58 HDR Plasmid (h) | sc-407615-HDR | 20 µg | $445.00 |
KDELC1 encodes EP58, an endoplasmic reticulum (ER)–associated protein implicated in protein quality control and secretory pathway homeostasis. EP58 is linked to ER retention/retrieval and may influence the unfolded protein response, ER-associated degradation, and trafficking of nascent glycoproteins through the early secretory system. By modulating ER proteostasis, KDELC1 can affect cellular stress adaptation, redox balance, and downstream signaling that impacts proliferation and survival. Dysregulation of ER stress and proteostasis networks is relevant to multiple disease contexts, including cancer biology and neurodegeneration, making KDELC1 a useful target for mechanistic studies of ER function.
EP58 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the KDELC1 gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the KDELC1 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, EP58 HDR Plasmid (h) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined KDELC1 target site.
When co-transfected with EP58 CRISPR/Cas9 KO Plasmid (h):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the KDELC1 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.